Ginger supplement tested as natural Anti-Inflammatory for heart health

NCT ID NCT07437222

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether taking ginger capsules daily for 60 days can lower inflammation and oxidative stress in adults with excess body fat. Fifty participants will be randomly assigned to receive either ginger or a placebo. The goal is to see if ginger can improve markers linked to heart disease risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ginger capsules

What this could lead to

If it works, this could point toward a simple, natural supplement to help control inflammation and reduce heart disease risk in people with excess weight.

What could go wrong

This is a small, early-stage trial with only 50 participants. The results may not apply to everyone, and ginger may not show a significant effect compared to placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OXIDATIVE STRESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Universidad Católica San Antonio de Murcia

    RECRUITING

    Murcia, Murcia, 30107, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••